Alkyl Amines Chemicals Ltd logo

Alkyl Amines Chemicals Ltd

ALKYLAMINE NSE

Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.

AI Verdict: HOLD Confidence: 4%

Alkyl Amines trades at a steep PE of 48.1x despite declining profits (TTM profit growth -3%) and weak sales growth of -2% TTM. The debt-free balance sheet and 30% dividend payout provide downside protection, but the stock needs to demonstrate earnings recovery before warranting a buy at current valuations.

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹9,058 Cr
Volatility
Moderate
P/E Ratio
50.82
EBITDA
₹264 Cr
Return on Equity
37.52%
Debt to Equity
0.28
Book Value
₹299.8
EPS
₹28.94
52W High
₹2,438.8
52W Low
₹1,212

Technical Indicators

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 30.1%

Weaknesses

2
  • The company has delivered a poor sales growth of 4.33% over past five years.
  • Company has a low return on equity of 12.8% over last 3 years.

Growth Rate

Revenue Growth
17.74% ↗
Net Income Growth
133.80% ↗
Cash Flow Change
30.25% ↗
ROE
65.21% ↗
ROCE
42.12% ↗
EBITDA Margin (Avg.)
34.27% ↗

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 26d ago
HOLD
Risk high

Alkyl Amines trades at a steep PE of 48.1x despite declining profits (TTM profit growth -3%) and weak sales growth of -2% TTM. The debt-free balance sheet and 30% dividend payout provide downside protection, but the stock needs to demonstrate earnings recovery before warranting a buy at current valuations.

Bull Case 8
  • Company is almost debt-free, providing strong financial resilience and flexibility for future capex
  • 10-year stock CAGR of 30% demonstrates long-term wealth creation track record
  • Healthy dividend payout ratio of 30.1% signals management confidence and shareholder-friendly capital allocation
  • 10-year compounded sales growth of 12% shows the business has a proven long-cycle growth runway
  • 10-year compounded profit growth of 14% indicates structural profitability over full business cycles
  • 5-year ROE of 16% reflects historically efficient capital deployment above cost of equity
  • 50% of analysts rate the stock a Buy, indicating some institutional confidence in recovery
  • Market cap of Rs 8,654 Cr provides reasonable liquidity and mid-cap institutional eligibility
Bear Case 8
  • PE of 48.1x is extremely elevated for a specialty chemicals company delivering negative profit growth of -3% TTM
  • 3-year compounded profit decline of -8% signals a sustained earnings deterioration, not a one-off
  • TTM sales growth of -2% and 5-year sales CAGR of just 4.33% indicate demand stagnation
  • ROE has declined from 21% (10-year average) to just 12% last year, showing margin compression
  • Stock has delivered -14% returns over 1 year and -12% CAGR over 3 years, underperforming broader markets significantly
  • 5-year stock CAGR of -15% suggests the market has been de-rating the stock for an extended period
  • Price-to-book of 5.64x is rich given the current ROE of only 12%, implying poor return on premium paid
  • 25% of analysts rate the stock a Sell, reflecting divided opinion on recovery prospects

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 25d ago
Headwinds 2
  • Ammonia supply disruption in March May 14

    Ammonia supply disruption in March impacted operations, contributing to flat FY26 volumes despite demand environment.

  • Flat FY26 volume growth May 14

    FY26 volumes remained flat year-on-year, indicating no organic growth was achieved during the fiscal year.

Positives 3
  • 5-10% volume growth guidance FY27 May 14

    Management guided for 5-10% volume growth in FY27, signaling recovery from the flat FY26 performance.

  • Cautious optimism on margins May 14

    Management expressed cautious optimism on margin improvement going forward, suggesting pricing and cost dynamics may be turning favorable.

  • ~₹80-90 Cr capex planned FY27 May 14

    Company plans ~₹80-90 Cr capex for FY27, indicating continued investment in capacity expansion.

Neutral 1
  • June 26 dividend record date May 28

    Record date for FY26 dividend set as June 26, 2026, subject to shareholder approval at the AGM.

TL;DR: Alkyl Amines had a subdued FY26 with flat volumes and an ammonia supply disruption in March, but management is guiding for 5-10% volume growth in FY27 with ~₹80-90 Cr capex. Margins outlook is cautiously optimistic. The trend appears to be stabilizing with a mild recovery expected, though execution on volume growth guidance will be key to watch.

Quarterly Results

  Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
412
410
352
322
357
400
415
371
386
406
389
354
387
Expenses
335
336
304
262
288
321
341
301
318
329
319
287
316
Operating Profit
78
74
48
60
69
79
74
71
68
77
70
67
71
OPM %
19%
18%
14%
19%
19%
20%
18%
19%
18%
19%
18%
19%
18%
Other Income
2
5
2
5
3
5
9
7
9
8
7
8
8
Interest
1
1
2
1
1
0
0
0
0
0
0
0
0
Depreciation
12
12
13
17
17
18
18
18
18
18
18
18
18
PBT
67
66
36
46
53
66
64
59
59
66
59
57
61
Tax %
28%
25%
25%
28%
28%
26%
26%
26%
22%
25%
27%
26%
25%
Net Profit
49
50
27
33
38
49
47
44
46
49
43
42
45
EPS in Rs
9.52
9.74
5.33
6.54
7.52
9.56
9.28
8.56
9
9.67
8.4
8.26
8.87
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
476
484
501
616
846
993
1,242
1,542
1,683
1,441
1,572
1,536
Expenses
390
393
405
499
682
736
812
1,216
1,335
1,189
1,280
1,251
Operating Profit
87
91
95
118
164
257
430
326
348
252
291
285
OPM %
18%
19%
19%
19%
19%
26%
35%
21%
21%
17%
19%
19%
Other Income
2
2
1
2
4
40
6
14
9
14
30
32
Interest
10
8
8
8
15
10
6
3
3
4
1
1
Depreciation
11
13
14
16
23
27
29
35
45
59
71
72
PBT
67
72
74
96
130
260
401
302
309
202
249
243
Tax %
32%
31%
32%
33%
36%
17%
26%
26%
26%
26%
25%
26%
Net Profit
45
50
50
64
84
215
295
225
229
149
186
180
EPS in Rs
8.91
9.77
9.87
12.61
16.42
42.21
57.91
44.04
44.75
29.12
36.39
35.19
Div. Payout %
18%
41%
20%
22%
20%
19%
17%
23%
22%
34%
28%
28%
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10
10
10
10
10
10
10
10
10
10
10
10
Reserves
165
189
235
287
355
526
782
980
1,159
1,257
1,392
1,523
Borrowings
135
111
120
181
165
87
47
23
88
3
6
1
Other Liabilities
93
95
147
159
218
160
306
359
335
314
381
362
Total Liabilities
402
406
512
637
749
783
1,145
1,371
1,592
1,584
1,789
1,896
Fixed Assets
151
187
220
355
376
423
458
629
719
1,089
1,044
1,015
CWIP
31
16
35
18
43
45
138
143
352
36
52
130
Investments
2
2
1
1
1
0
30
0
0
0
0
51
Other Assets
218
201
256
262
328
315
520
600
521
459
693
700
Total Assets
402
406
512
637
749
783
1,145
1,371
1,592
1,584
1,789
1,896
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
61
101
63
102
144
188
364
205
248
275
263
239
Investing
-31
-35
-65
-132
-67
-41
-213
-206
-277
-121
-196
-137
Financing
-36
-68
-2
32
-60
-135
-86
-57
8
-140
-49
-56
Net Cash Flow
-6
-2
-3
2
17
12
65
-58
-21
13
18
45
Free Cash Flow
20
66
-1
-33
75
111
208
-41
-55
153
216
111
CFO/OP
95
128
88
103
109
96
108
86
92
123
108
101
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
76
68
71
73
66
60
67
66
56
56
54
55
Inventory Days
105
92
165
99
88
67
91
76
82
85
75
57
Days Payable
58
63
120
78
104
57
133
105
84
85
80
70
Cash Conversion Cycle
123
96
116
94
51
71
25
36
53
56
48
42
Working Capital Days
93
87
84
76
56
54
26
35
28
47
42
49
ROCE %
26%
26%
24%
25%
29%
41%
56%
33%
28%
16%
19%
17%

Shareholding Pattern

As of Mar 2026
Promoters 72.05%
Public 17.30%
Others 4.19%
FIIs 3.45%
DIIs 3.01%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters
74.13%
74.09%
72.03%
72.03%
72.03%
72.00%
71.99%
71.99%
71.99%
71.97%
71.96%
71.96%
71.96%
71.97%
71.96%
72.00%
72.04%
72.03%
72.03%
72.03%
72.05%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
2.94%
3.04%
3.10%
3.20%
3.23%
3.23%
3.25%
3.43%
3.46%
3.45%
DIIs
1.40%
0.92%
0.86%
0.88%
0.63%
0.72%
0.57%
1.12%
1.14%
0.57%
0.58%
1.07%
1.10%
1.07%
1.53%
1.76%
2.18%
2.61%
2.88%
3.00%
3.01%
Government
0.46%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
18.76%
19.67%
20.40%
20.09%
20.71%
20.50%
20.21%
19.64%
19.45%
19.34%
19.39%
19.47%
19.42%
19.35%
18.95%
18.72%
18.30%
17.95%
17.52%
17.30%
17.30%
Others
5.25%
5.32%
6.72%
7.00%
6.64%
6.79%
7.24%
7.26%
7.42%
8.12%
8.07%
4.57%
4.48%
4.51%
4.36%
4.28%
4.25%
4.16%
4.14%
4.22%
4.19%
No. of Shareholders
59,813
1,11,477
1,73,629
1,93,539
2,13,305
2,15,327
2,16,512
2,08,334
2,03,677
2,01,859
1,99,781
1,97,171
1,92,885
1,87,077
1,79,008
1,74,927
1,68,960
1,61,021
1,53,451
1,49,324
1,46,028

Documents

Frequently Asked Questions about Alkyl Amines Chemicals Ltd

What does Alkyl Amines Chemicals Ltd do?
Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.
Where is Alkyl Amines Chemicals Ltd (ALKYLAMINE) listed?
Alkyl Amines Chemicals Ltd is listed on the Indian stock exchanges. It is listed on NSE: ALKYLAMINE and BSE: 506767. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Alkyl Amines Chemicals Ltd belong to?
Alkyl Amines Chemicals Ltd operates in the Commodities sector within the Chemicals & Petrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Alkyl Amines Chemicals Ltd?
Alkyl Amines Chemicals Ltd has a market capitalisation of approximately ₹9057.61 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Alkyl Amines Chemicals Ltd?
The Price-to-Earnings (PE) ratio of Alkyl Amines Chemicals Ltd is 50.82. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Alkyl Amines Chemicals Ltd?
Over the past 52 weeks, Alkyl Amines Chemicals Ltd has traded between a low of ₹1,212 and a high of ₹2,438.8. This range helps investors understand the stock's price volatility and recent trading levels.
Does Alkyl Amines Chemicals Ltd pay dividends?
Yes, Alkyl Amines Chemicals Ltd has a dividend yield of 0.56%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Alkyl Amines Chemicals Ltd?
Alkyl Amines Chemicals Ltd has a Return on Equity (ROE) of 37.52%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Alkyl Amines Chemicals Ltd on Tapetide?
On Tapetide, you can view Alkyl Amines Chemicals Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.

Website alkylamines.com
CEO Mr. Yogesh Mathradas Kothari
Employees 686
Listed 2007-11-26
Face Value ₹ 2
Issued Size 5,11,44,052

Explore More

More in Commodities → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List